Internal Medicine, Nephrology · Fayetteville, GA
NPI
1659626349
Since 2012
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1275 Highway 54 W Ste 100
Fayetteville, GA, 30214
Phone (678) 817-5542
Groups this clinician bills Medicare through
Medicare paid, 2024
$175K
1,916 services
Medicare patients, 2024
577
Average age 76
Drug cost, 2024
$2.0M
1,785 prescriptions
Company payments, 2025
$1,262
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sushma Reddycherla was code 99232 (hospital e&m - subsequent), 844 times for 284 patients. In total Sushma Reddycherla billed 1,916 services in 20 codes, and Medicare paid $175K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 844 | 284 | $59.07 | $50K |
| 99233 Hospital E&M - Subsequent | Facility | 298 | 118 | $92.65 | $28K |
| 99214 Office E&M - Established | Office | 252 | 152 | $87.13 | $22K |
| 99222 Hospital E&M - Initial | Facility | 95 | 93 | $101.16 | $9,611 |
| 99223 Hospital E&M - Initial | Facility | 78 | 75 | $133.07 | $10K |
| 90961 ESRD Related Services (not dialysis) | Office | 66 | 19 | $223.89 | $15K |
| 90960 ESRD Related Services (not dialysis) | Office | 58 | 14 | $274.26 | $16K |
| 99204 Office E&M - New | Office | 37 | 37 | $111.87 | $4,139 |
| 90935 Hemodialysis | Facility | 35 | 25 | $53.88 | $1,886 |
| 99215 Office E&M - Established | Office | 35 | 30 | $119.93 | $4,197 |
| 99213 Office E&M - Established | Office | 19 | 17 | $63.40 | $1,205 |
| 99291 Critical Care E&M | Facility | 19 | 13 | $168.79 | $3,207 |
| 99231 Hospital E&M - Subsequent | Facility | 13 | 12 | $37.51 | $488 |
By year: 2022 $193K for 2,019 services; 2023 $218K for 2,599 services; 2024 $175K for 1,916 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sushma Reddycherla prescribed most often to Medicare patients was Calcitriol, with 139 prescriptions and refills. In total Sushma Reddycherla wrote 1,785 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 139 | 358 | 51 | $1,932 |
| Amlodipine Besylate Generic | 135 | 384 | 53 | $854 |
| Allopurinol Generic | 133 | 341 | 46 | $1,239 |
| Farxiga Dapagliflozin Propanediol | 115 | 222 | 37 | $119K |
| Losartan Potassium Generic | 101 | 286 | 42 | $883 |
| Jardiance Empagliflozin | 89 | 207 | 32 | $119K |
| Lisinopril Generic | 75 | 221 | 31 | $627 |
| Hydrochlorothiazide Generic | 57 | 156 | 21 | $259 |
| Krystexxa Pegloticase | 57 | 57 | Under 11 | $1.6M |
| Furosemide Generic | 51 | 131 | 20 | $189 |
| Potassium Chloride Generic | 48 | 102 | 22 | $1,705 |
| Nifedipine Er Nifedipine | 43 | 90 | 17 | $1,052 |
| Hydralazine Hcl Generic | 42 | 102 | 21 | $471 |
| Olmesartan Medoxomil Generic | 35 | 100 | 18 | $625 |
| Lokelma Sodium Zirconium Cyclosilicate | 34 | 60 | 16 | $16K |
Brand drugs: 417 claims; generic drugs: 1,368 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sushma Reddycherla $1,262 ($1,262 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $327.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 6 | $327 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $191 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $138 |
| Vantive US Healthcare LLC | 2 | $121 |
| Fresenius USA Marketing, Inc. | 3 | $69.72 |
| OPKO Pharmaceuticals, LLC | 3 | $68.55 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $66.69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42.52 |
| Ardelyx, Inc. ARDX | 2 | $42.4 |
| Travere Therapeutics, Inc. TVTX | 6 | $42.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.